Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Science Foundation (DGE-2038238)
National Institutes of Health (K12-GM068524, RF1-MH126719)
National Human Genome Research Institute (R01-HG004659, R01-HG011864, U41/U24-HG009889)
- License Information
-
More Information
Article History
Received: 20 October 2022
Accepted: 22 August 2023
First Online: 2 October 2023
Declarations
:
: Not applicable.
: Not applicable.
: G.W.Y. is a cofounder, member of the board of directors, equity holder, and paid consultant for Locanabio and Eclipse BioInnovations and a distinguished visiting professor at the National University of Singapore. The terms of these arrangements have been reviewed and approved by University of California San Diego in accordance with its conflict-of-interest policies. The authors declare no other competing interests.
